Construction and investigation of β3GNT2-associated regulatory network in esophageal carcinoma
Open Access
- 24 January 2022
- journal article
- research article
- Published by Springer Nature in Cellular & Molecular Biology Letters
- Vol. 27 (1) , 1-18
Abstract
Glycosyltransferases play a crucial role in various cancers. β1, 3-N-acetylglucosaminyltransferase 2, a polylactosamine synthase, is an important member of the glycosyltransferase family. However, the biological function and regulatory mechanism of β3GNT2 in esophageal carcinoma (ESCA) is still poorly understood. The Cancer Genome Atlas and Genotype-Tissue Expression databases were used for gene expression and prognosis analysis. Quantitative real-time PCR, Western blot, and immunohistochemistry were performed to detect the expression of β3GNT2 in ESCA cell lines and tissues. In vitro assays and xenograft tumor models were utilized to evaluate the impact of β3GNT2 on ESCA progression. The downstream effectors and upstream regulators of β3GNT2 were predicted by online software and verified by functional experiments. We found that β3GNT2 was highly expressed in ESCA tissues and positively correlated with poor prognosis in ESCA patients. β3GNT2 expression was closely associated with the tumor size, TNM stage, and overall survival of ESCA patients. Functionally, β3GNT2 promoted ESCA cell growth, migration, and invasion in vitro, as well as tumorigenesis in vivo. Mechanistically, β3GNT2 knockdown decreased the expression of the polylactosamine on EGFR. Knockdown of β3GNT2 also inhibited the JAK/STAT signaling pathway. Meanwhile, the JAK/STAT inhibitor could partly reverse the biological effects caused by β3GNT2 overexpression. Moreover, β3GNT2 expression was positively regulated by CREB1 and negatively regulated by miR-133b. Both CREB1 and miR-133b was involved in the β3GNT2-mediated ESCA progression. Our study, for the first time, reveals the importance of β3GNT2 in ESCA progression and offers a potential therapeutic target for ESCA.Keywords
Funding Information
- Hubei Provincial Department of Science and Technology Innovation Group program (No.2019CFA034)
This publication has 31 references indexed in Scilit:
- MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancerCell Death & Disease, 2018
- Role of N‐glycosylation in EGFR ectodomain ligand bindingProteins: Structure, Function, and Bioinformatics, 2017
- β3GnT2 null mice exhibit defective accessory olfactory bulb innervationMolecular and Cellular Neuroscience, 2013
- JAK/STAT signal pathway activation promotes progression and survival of human oesophageal squamous cell carcinomaClinical and Translational Oncology, 2012
- O-linked N-acetylglucosamine transferase (OGT) is overexpressed and promotes O-linked protein glycosylation in esophageal squamous cell carcinomaJournal of Biomedical Research, 2012
- Expression of β1,3-N-acetylglucosaminyltransferases during differentiation of human acute myeloid leukemia cellsMolecular and Cellular Biochemistry, 2011
- Association of -1,3-N-acetylglucosaminyltransferase 1 and -1,4-galactosyltransferase 1, trans-Golgi enzymes involved in coupled poly-N-acetyllactosamine synthesisGlycobiology, 2009
- Polylactosamine on glycoproteins influences basal levels of lymphocyte and macrophage activationProceedings of the National Academy of Sciences, 2007
- Human glycogene cloning: focus on β3-glycosyltransferase and β4-glycosyltransferase familiesCurrent Opinion in Structural Biology, 2006
- A novel β1,3-N-acetylglucosaminyltransferase involved in invasion of cancer cells as assayed in vitroBiochemical and Biophysical Research Communications, 2002